Cite
HARVARD Citation
Sandborn, W. et al. (n.d.). Transient Anti‐Drug Antibodies and Their Impact on Markers of Inflammation: Longitudinal Data From a 7‐Year Study of Certolizumab Pegol in Crohn's Disease Patients. American journal of gastroenterology. p. . [Online].